Real-time Eye Tracking and Imaging of the Eye in Diabetic Retinopathy Patients

Overseen By Study Coordinator

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: PulseMedica

Disqualifiers: Age, No diabetic retinopathy, Opacification

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

60 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial is testing a new camera called the OSNAT800 IO that takes 3D pictures of the back of the eye and tracks eye movements in real-time. It aims to help doctors monitor patients with diabetic retinopathy, a common cause of vision loss. The goal is to see if this device can accurately track eye movements while taking detailed images.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

Are You a Good Fit for This Trial?

Inclusion Criteria

Male or female

Diagnosed diabetic retinopathy

Two eyes with clear ocular media

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Retinal Imaging

Participants undergo retinal imaging using the OSNAT800 IO device to assess real-time eye tracking capabilities

Single session

1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after imaging

6 months

What Are the Treatments Tested in This Trial?

Interventions

• OSNAT 800 IO

How Is the Trial Designed?

Group I: Retinal Imaging using the OSNAT800 IO device Experimental Treatment 1 Intervention

Patients will have their eyes imaged with the OSNAT800 IO device in addition to a routine standard of care appointment.

Who Is Running the Clinical Trial?

PulseMedica

Lead Sponsor

Trials

3

Recruited

340+